[Source: Wuxi Technology]
On the afternoon of July 24, the "Medical Device Overseas Strategy" enterprise salon sponsored by Wuxi Biomedical Industry Development Promotion Center and Wuxi Biomedical Industry Association was successfully held. More than 50 people, including representatives of medical device companies and industry experts, participated in the event, focusing on the medical device market from a global perspective and drawing a new blueprint for pharmaceutical going overseas.
Zhang Yajun, director of the Wuxi Inspection Branch of the Provincial Food and Drug Administration and director of the Municipal Biomedical Industry Development Promotion Center, said in his speech that the medical device industry is an important part of the biomedical field, and the medical device industry has ushered in a new situation of coexistence of opportunities and challenges in the global medical device market. The purpose of this salon is to discuss the coping strategies of medical device companies going overseas, further help enterprises grasp investment opportunities, enhance risk prevention capabilities, and help enterprises better "go global".
Xu Chongyuan, chief expert of Wuxi Biomedical Industry Association, delivered a keynote speech, in-depth discussion of the current international and domestic biomedical industry market development status, and presented the macro trend of the industry for the participants. She pointed out that medical device companies should consider R&D, manufacturing, supply chain, marketing chain and other aspects, and achieve successful "going overseas" by formulating strategic goals, identifying development positioning, and global comprehensive layout.
With the acceleration of the internationalization of the medical device industry, cross-border data compliance issues are becoming increasingly prominent. Wu Bin, a business partner of Beijing Deheng (Wuxi) Law Firm, provided professional insights and guidance for enterprises in the process of going overseas by interpreting typical cases and analyzing internal rules for this cutting-edge issue.
Niu Xuesong, manager of Wuxi Medi Zhilian Biotechnology Co., Ltd., analyzed the "registration and filing of medical devices" and described the specific requirements of relevant laws and regulations.
Geng Jian, Wuxi Inspection Branch of the Provincial Food and Drug Administration, gave a detailed explanation of the "Analysis of the Medical Device Registrant System and Declaration Path", and helped enterprises understand the relevant policies with full of "dry goods".
In the interactive exchange session, the participants actively spoke, putting forward the confusion and demands encountered by enterprises in "going to sea", and the atmosphere was warm.
Wuxi Biomedical Industry Development Promotion Center takes industrial services as its own responsibility, and has effectively promoted the healthy development of the biomedical industry through measures such as "focusing on enterprise development, assisting in strategic planning and cultivating services", "focusing on collaborative linkage, building a multi-level service system", "focusing on key projects, and implementing special personnel, special classes, and special projects". In the future, the promotion center will continue to hold theme salon activities, build a bridge for the deep integration of government, industry, academia, research, capital and other forces, create a platform for ideological collision and wisdom exchange, stimulate industrial vitality and innovation power, and empower the transformation and upgrading and high-quality development of the biomedical industry.
Editor: Shao Zhihua
Review: Lv Huawei, Yue Xuetong
Review: Zhu Huazhang
Published by: Shao Zhihua
Disclaimer: The copyright of this article belongs to the original author, if there is a source error or infringement of your legitimate rights and interests, you can contact us by email, we will deal with it in a timely manner. E-mail address: [email protected]